Screener
Rigel Pharmaceuticals RIGL Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's operating margin?
- Rigel Pharmaceuticals (RIGL) reported operating margin of 41.6% in Q1 2026.
- How has Rigel Pharmaceuticals's operating margin changed year-over-year?
- Rigel Pharmaceuticals's operating margin increased by 92.1% year-over-year, from 21.6% to 41.6%.
- What is the long-term trend for Rigel Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's operating margin has grown at a 9.8% compound annual growth rate (CAGR), from -26.7% to 42.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Rigel Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude